Thermo Fisher Scientific
TMO
1,006 hedge funds and large institutions have $53B invested in Thermo Fisher Scientific in 2015 Q4 according to their latest regulatory filings, with 98 funds opening new positions, 352 increasing their positions, 404 reducing their positions, and 52 closing their positions.
88% more first-time investments, than exits
New positions opened: 98 | Existing positions closed: 52
64% more call options, than puts
Call options by funds: $310M | Put options by funds: $189M
28% more funds holding in top 10
Funds holding in top 10: 69 → 88 (+19)
15% more capital invested
Capital invested by funds: $46B → $53B (+$6.97B)
4% more funds holding
Funds holding: 970 → 1,006 (+36)
0.9% less ownership
Funds ownership: 89.95% → 89.05% (-0.9%)
13% less repeat investments, than reductions
Existing positions increased: 352 | Existing positions reduced: 404
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$172M |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$125M |
| 3 |
FAM
Fred Alger Management
New York
|
+$103M |
| 4 |
FPP
Findlay Park Partners
London,
United Kingdom
|
+$101M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$81.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Sculptor Capital
New York
|
-$496M |
| 2 |
GCM
Glenview Capital Management
New York
|
-$344M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$151M |
| 4 |
BRC
Blue Ridge Capital
New York
|
-$133M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
-$88.7M |
TMO Hedge Fund Activity: Q4 2015 in Review
1,006 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q4 2015, worth a combined $53B — up 15% from $46B a quarter earlier.
Buyers outnumbered sellers: 98 funds opened new TMO positions and 52 closed out — a net gain of 46 holders — while 352 added to existing stakes and 404 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $172M. The largest seller was Sculptor Capital, exiting entirely with an estimated $496M sold.
- 1,006 institutional investors held Thermo Fisher Scientific (TMO) as of Q4 2015, up from 970 in Q3 2015.
- Funds reported $53B of Thermo Fisher Scientific stock for Q4 2015, up 15% quarter-over-quarter.
- 98 funds opened new Thermo Fisher Scientific positions in Q4 2015 and 52 closed out, a net change of +46 holders.
- The largest Thermo Fisher Scientific buyer in Q4 2015 was T. Rowe Price Associates, an estimated $172M added.
- The largest Thermo Fisher Scientific seller in Q4 2015 was Sculptor Capital, an estimated $496M sold.
Based on aggregated 13F filings for Q4 2015.